AgomAb Therapeutics NV

formerly Agomab TherapeuticsIPO

Agomab Therapeutics – building a company focused on treating fibrosis

Public · Antwerp, Belgium · Founded 2017 · $337.8M raised

Headquarters
Antwerp
Employees
11–50
Founded
2017
Business Model
B2B
Website
agomab.com
Total Funding
$337.8M
Last Round
$89.0M Series DJan 2024
Rounds
7
Type
Public

About

Agomab Therapeutics is a clinical-stage biopharmaceutical company developing innovative therapies targeting the HGF/MET signaling pathway for fibrotic and inflammatory diseases. Founded in 2017 and headquartered in Ghent, Belgium, the company's lead programs focus on conditions such as IBD, liver fibrosis, and AKI, with a pipeline of engineered agonist antibodies designed to promote tissue regeneration and repair.

Summary

AgomAb Therapeutics NV is a Biotech company based in Antwerp, Belgium, founded in 2017. It has raised $337.8M in total across 7 rounds, most recently a $89.0M Series D round in Jan 2024. Investors include Fidelity Management, Pfizer Ventures and Novo Holdings A/S.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOJan 2025
$182.0M

Sign up to see all 8 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AgomAb Therapeutics NV on Indexed.vc
<a href="https://indexed.vc/companies/agomab-therapeutics-nv"><img src="https://indexed.vc/api/badge/company/agomab-therapeutics-nv" alt="AgomAb Therapeutics NV on Indexed.vc" width="260" height="76" /></a>